16 filings
8-K
TYME
Tyme Technologies Inc
18 Oct 19
Entry into a Material Definitive Agreement
10:15am
8-K
TYME
Tyme Technologies Inc
17 Oct 19
TYME Presents Business Update and Announces Second
4:15pm
8-K
TYME
Tyme Technologies Inc
25 Sep 19
Other Events
8:03am
8-K
TYME
Tyme Technologies Inc
27 Aug 19
Submission of Matters to a Vote of Security Holders
4:49pm
8-K
TYME
Tyme Technologies Inc
9 Jul 19
Regulation FD Disclosure
7:30am
8-K
6nfh8tyn e0u2lj
5 Jul 19
TYME Presents Updated Data at ESMO GI 2019 fromTYME-88-Panc
8:00am
8-K
p5pnbmo4
29 May 19
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
7:46am
8-K
7lyjpw3
20 May 19
TYME Announces Notification of Issuance of U.S. Patent Covering
8:00am
8-K
bqfdr
2 Apr 19
Entry into a Material Definitive Agreement
5:03pm
8-K
io7veggyhq9wg1
18 Mar 19
Departure of Directors or Certain Officers
8:01am
8-K
tb670okn
25 Feb 19
TYME Receives FDA Guidance on Pivotal Trial forSM-88 in Treatment for Advanced Pancreatic Cancer
8:02am
8-K
bixagcfu2576yqch4g
14 Feb 19
Other Events
8:03am
8-K
l1mtscw
18 Jan 19
Regulation FD Disclosure
12:50pm
8-K
935co0xpc6rwmdu2 0cy
18 Jan 19
TYME’s Novel Metabolic-Based Cancer Therapy,SM-88, Improves Survival in Phase II Study of Patients with Advanced Pancreatic Cancer
12:00am
8-K
6kaczo85
15 Jan 19
Tyme Schedules Conference Call to DiscussSM-88 Preliminary Phase II Pancreatic Cancer Data on Friday, January 18th
8:00am
8-K
9td7bctzc12p50i
3 Jan 19
Other Events
8:06am
- Prev
- 1
- Next